Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1956 1
1962 1
1963 1
1965 1
1972 2
1973 2
1977 2
1978 1
2012 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K; EMPRISE EU; East Asia Study Group. Vistisen D, et al. Cardiovasc Diabetol. 2023 Aug 31;22(1):233. doi: 10.1186/s12933-023-01963-9. Cardiovasc Diabetol. 2023. PMID: 37653496 Free PMC article.
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study.
Langslet G, Nyström T, Vistisen D, Carstensen B, Grip ET, Casajust P, Tskhvarashvili G, Hoti F, Klement R, Karlsdotter K, Tuovinen M, Ofstad AP, Lajer M, Shay C, Koeneman L, Farsani SF, Niskanen L, Halvorsen S. Langslet G, et al. Among authors: tuovinen m. J Diabetes Res. 2024 Oct 12;2024:6142211. doi: 10.1155/2024/6142211. eCollection 2024. J Diabetes Res. 2024. PMID: 39430801 Free PMC article.
Creutzfeldt-Jakob disease.
HILLBOM E, TUOVINEN M, DE LA CHAPELLE A. HILLBOM E, et al. Among authors: tuovinen m. Ann Med Intern Fenn Suppl. 1962;(Suppl 38):59-72. Ann Med Intern Fenn Suppl. 1962. PMID: 13907395 No abstract available.
[Criminal patients].
Tuovinen M. Tuovinen M. Duodecim. 1973;89(13):950-4. Duodecim. 1973. PMID: 4761197 Finnish. No abstract available.
Present functions of forensic psychiatry in Scandinavia.
Svendsen BB, Anchersen P, Meyerson A, Noriek K, Thorsteinsson G, Tuovinen M, Törnqvist KE. Svendsen BB, et al. Among authors: tuovinen m. Acta Psychiatr Scand. 1977 Mar;55(3):165-75. doi: 10.1111/j.1600-0447.1977.tb00155.x. Acta Psychiatr Scand. 1977. PMID: 848331
[Can we abolish forensic psychiatry?].
Tuovinen M. Tuovinen M. Nord Med. 1972 Dec;87(10):305-6. Nord Med. 1972. PMID: 4635051 Swedish. No abstract available.
[Psychic factors and sauna baths].
Ihalainen O, Hirvenoja R, Tuovinen M. Ihalainen O, et al. Among authors: tuovinen m. Duodecim. 1973;89(4):325-31. Duodecim. 1973. PMID: 4688465 Finnish. No abstract available.
16 results